What Wegovy does in your stomach — and what that means for you

Step 1, How semaglutide reaches your digestive system

Wegovy is injected once a week under the skin of the abdomen, thigh or upper arm. It does not go directly into the bloodstream from the stomach the way a tablet would; subcutaneous injection means the medicine is absorbed from the tissue beneath the skin and circulates systemically. Once in the bloodstream, semaglutide binds to GLP-1 receptors throughout the body, including in the gut wall, the pancreas and the brain. As the NHS semaglutide medicines page explains, this GLP-1 receptor activity is what drives both the blood-sugar effects and the appetite effects people on Wegovy experience.

The stomach itself feels the consequences rather than absorbing the drug. GLP-1 receptor activation slows a process called gastric emptying: the rate at which the stomach contracts to push food into the small intestine. Food lingers. The stomach stretches for longer. Stretch receptors in the stomach wall send satiety signals to the brain earlier and more persistently than they would normally. That is the core mechanism behind reduced appetite, not a direct effect on the brain alone, but a chain of signals that starts in the gut. Learn more about how semaglutide works across the body.

Step 2, The first weeks: what the stomach goes through

Most of the gut-related effects reported by people on Wegovy happen in the first four to eight weeks, and again briefly after each dose increase. Nausea is the most common, affecting a significant proportion of users at some point during treatment. Vomiting, loose stools, constipation, excess burping and a feeling of heaviness or bloating after small meals are also frequently reported, all consistent with food moving more slowly through the digestive tract than the gut is accustomed to.

Timing matters here. Symptoms tend to peak in the day or two after an injection and then settle until the next dose. Eating smaller portions, avoiding very fatty or heavily spiced food, and staying hydrated helps most people manage this period. If nausea is bad enough to stop you eating or drinking properly, that is worth raising with your prescriber rather than waiting it out. Our guide to Wegovy stomach pain covers the distinction between expected discomfort and symptoms that need attention, and if you want practical steps to ease things, these approaches are worth reading.

Treatment starts at 0.25 mg, a low dose whose job is to let the digestive system acclimatise before the dose is increased by your prescriber, typically every four weeks. That staged titration exists precisely because the stomach-related effects are dose-dependent: the stronger the GLP-1 signal, the more pronounced the slowing of gastric emptying.

Step 3, Adjusting over time

For most people, the stomach adjusts. The body's compensatory mechanisms partially counteract the slowing effect on gastric emptying as weeks pass, which is why nausea that felt constant in week two often becomes mild or absent by week six. Weight loss itself also changes the gut environment over time, since the hormonal profile of adipose tissue shifts as it reduces.

That said, some people experience persistent digestive symptoms at higher doses. If symptoms return or worsen after a dose increase, that is normal and expected; if they do not settle after a week or two at the new dose, your prescriber can discuss slowing the titration or pausing it. A stomach-flu-like episode during Wegovy treatment raises its own questions, this page separates what's the medicine and what's something else. Keeping a brief note of when symptoms happen relative to injection day helps your prescriber a great deal.

One symptom pattern that is never normal: severe stomach pain that builds gradually, feels persistent rather than wave-like, and radiates towards the back. On 29 January 2026 the MHRA issued a Drug Safety Update highlighting acute pancreatitis as an infrequent but serious risk with GLP-1 medicines, and advising patients to seek urgent medical help for this symptom combination. You can also report any suspected side effects via the MHRA Yellow Card scheme. If what you are experiencing sounds more like a persistent stomach ache rather than acute pain, our dedicated page on stomach ache during Wegovy covers the milder end of the spectrum.

What the injection site in the stomach means for delivery

A quick practical note, because people sometimes confuse injecting into the stomach area with what the medicine does in the stomach. The abdomen is simply one of three approved injection sites, rotating between the abdomen, thigh and upper arm reduces skin irritation at any single spot. The medicine is not going into the stomach organ; it is going into subcutaneous fat beneath the skin of the belly, where it is absorbed. Injecting into the abdomen is not more effective than the thigh or arm; it is simply a matter of preference and rotation.

When your Wegovy prescription is dispensed through a regulated UK pharmacy, the pen arrives in plain, unbranded packaging via a next-working-day tracked delivery, along with the Patient Information Leaflet that walks through the injection technique step by step. The leaflet is the definitive guide on rotation, needle depth and timing. For more on injection site choices (including whether the leg is a reasonable alternative) this comparison page is worth a read.

If you are weighing up Wegovy for weight management, the starting point is a clinical consultation. See what Wegovy costs through a private pharmacy, or check your eligibility and start a free consultation with our prescribers.